LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Orgenesis (NASDAQ: ORGS)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ORGS Orgenesis
Adler Yaron / director
12/12/2024
Buy
$0.98
1,750
$2K
1,750
NASDAQ ORGS Orgenesis
PELAVIN ADAM / director
12/12/2024
Buy
$0.98
1,250
$1K
1,250
NASDAQ ORGS Orgenesis
PELAVIN ADAM / director
12/12/2024
Buy
$0.98
625
$613
625
NASDAQ ORGS Orgenesis
Nanda Ashish / director
12/12/2024
Buy
$0.98
1,835
$2K
1,835
NASDAQ ORGS Orgenesis
NAGARAJ SANTHOSH / director
12/12/2024
Buy
$0.98
1,250
$1K
1,250
NASDAQ ORGS Orgenesis
NAGARAJ SANTHOSH / director
12/12/2024
Buy
$0.98
625
$613
625
NASDAQ ORGS Orgenesis
Vider Itzhak / director
12/12/2024
Buy
$0.98
1,500
$1K
1,500
NASDAQ ORGS Orgenesis
BHALAJI JAGANNATHAN / director
12/12/2024
Buy
$0.98
1,250
$1K
1,250
NASDAQ ORGS Orgenesis
BHALAJI JAGANNATHAN / director
12/12/2024
Buy
$0.98
625
$613
625
NASDAQ ORGS Orgenesis
Safier Jacob / 10 percent owner
11/04/2024
Buy
$1.03
242,718
$250K
242,718

COPYRIGHT ©2023 HEALTH STOCKS HUB